Indian CEOs On Plugging Quality Gaps: Yes We Can

The top bosses of six leading Indian firms were unequivocal that there is room for improvement on the quality front at a recent conference in Mumbai, but they also emphasized senior management engagement and resolve to get a "quality movement" going in their respective firms and in the domestic industry, in general.

The head honchos of Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., Lupin Ltd. and Zydus Cadila sat through day-long sessions at the India Pharmaceutical Forum 2016, where officials from the US FDA, MHRA and the EMA identified critical issues around quality challenges.

The Indian industry leaders, in the closing session, then outlined how they hoped to tackle some of these concerns.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Torrent Acquires JB Chem In 2025’s Biggest Deal For Indian Pharma

01 Jul 2025

• By Vibha Ravi

Torrent Pharma’s JB Chemicals acquisition follows the Curatio deal and Boehringer brands buyout. The second-biggest deal ever and the largest in 2025 among domestic pharma companies helps Torrent fill white spaces in areas like nephrology and gives an entry into the CDMO segment

Snapshot Of India’s Pharma Manufacturing Network Amid ‘Trumponomics’

27 Jun 2025

• By Anju Ghangurde

Scrip collates data on the global manufacturing network of leading Indian drug makers, the markets serviced and production hubs for active pharmaceutical ingredients. Will ongoing geopolitical tensions and policy shifts have a bearing on some of these down the line?

GSK, Bharat On Shigella Vaccine Phase II Data Timelines, Malaria Vaccine Price Halving